GMGeorge Nilton Nunes Mendes

George Nilton Nunes Mendes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


George Nilton Nunes Mendes has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Navigating the new frontier: technical, humanistic, and ethical skills in AI-augmented stroke care for vascular neurologists: a scoping review

    by João Brainer Clares de Andrade, Rafael Pádua Gomes, Alexandre Cristiuma Robles, George Nunes Mendes, Thales Pardini Fagundes, Thiago Santos Carneiro

  • Open Access

    Endovascular Acute Stroke Intervention–Tandem Occlusion (EASI-TOC) study: protocol and rationale

    by George N Mendes, Grégory Jacquin, Daniela Iancu, Daniel Roy, Michael Yu, Paule Bodson-Clermont, Imene Fahmi, Syed Uzair Ahmed, Mohammed Almekhlafi, Brian Buck, et al.

    Background: Patients with stroke due to symptomatic intracranial occlusion and concurrent symptomatic high-grade cervical internal carotid artery (ICA) stenosis (≥70%) or occlusion constitute 15%–20% of patients undergoing EVT. The optimal management of the cervical ICA in these tandem lesions remains unknown. We hypothesise that acute carotid artery stenting in addition to EVT will improve functional outcomes when compared with EVT alone. Study design: Endovascular Acute Stroke Intervention–Tandem Occlusion (EASI-TOC) is a multicentre, prospective, randomised, open-label, blinded end-point (PROBE) controlled trial. Adult patients with a disabling acute anterior circulation stroke (intracranial carotid, M1 or M2 segment occlusion) and salvageable brain tissue who undergo EVT within 24 h of onset, are eligible for enrolment if they have an angiographically confirmed atherosclerotic carotid tandem lesion. Patients are randomised 1:1 to acute carotid stenting or no stenting during EVT. Study endpoints: The primary outcome is the proportion of patients achieving a favourable functional outcome (mRS 0–2) at 90 days. Secondary outcomes include 12-month mRS, recanalisation, the 90-day rate of recurrent ipsilateral stroke or retinal ischaemia, the proportion of patients with ICA thrombosis, 90-day Montreal Cognitive Assessment score and quality of life. Safety outcomes include any ICH, sICH, all-cause mortality and procedural complications. Summary: Endovascular Acute Stroke Intervention—Tandem Occlusion is a pragmatic trial addressing a critical gap in the acute management of patients with tandem carotid lesions by evaluating whether acute carotid stenting provides a functional benefit over no stenting in patients undergoing EVT. Trial registration: ClinicalTrials.gov NCT04261478.


  • Livedo racemosa and multiple embolic strokes

    by George Nunes Mendes, Raphaël Livernoche, Celine Odier, Alex Bourguignon, Darosa Lim, Danielle Bouffard, Olena Bereznyakova

  • Local anesthesia is associated with better functional outcomes than conscious sedation in endovascular thrombectomy for acute ischemic stroke: A retrospective analysis of the OPTIMISE registry

    by George Nunes Mendes, Alexandre Y Poppe, Steve Verreault, Alexander Khaw, Richard Swartz, Darren Ferguson, Aditya Bharatha, David Volders, Grant Stotts, Aristeidis Katsanos, et al.

    Introduction: There are several possible anesthetic strategies during endovascular therapy (EVT) for acute ischemic stroke (AIS), including general anesthesia (GA), conscious sedation (CS), and local anesthesia (LA). While randomized trials have not shown a clear advantage of GA or CS, LA remains understudied. We aimed to determine if LA is associated with better functional outcomes compared to CS in a Canadian EVT registry. Patients and Methods: A retrospective analysis of the OPTIMISE registry was conducted, focusing on adult patients with anterior circulation AIS treated with EVT between January 2018 and December 2021. Patients with available information regarding anesthetic modality and 3-month functional outcome were included. The primary endpoint was a favorable functional outcome at 3 months (defined as a modified Rankin Scale score of 0–2) when using LA compared to CS (average treatment effect [ATE] determined by targeted maximum likelihood estimation). Secondary outcomes included procedural time, favorable reperfusion, complications, and symptomatic intracranial hemorrhage. Results: A total of 2204 patients were included in the analysis (763 LA, 1441 CS). In the LA group, 57.5% (n = 439) had a favorable outcome at 3 months compared to 55.6% (n = 801) in the CS group (ATE 0.04 [0.00–0.07]; adjusted odds ratio 1.16 [1.01–1.34]; p = 0.04). No significant difference was found between groups regarding reperfusion rates, procedural times, and symptomatic intracranial hemorrhage. Conclusion: In this large, Canadian multicenter cohort of patients undergoing EVT for anterior circulation AIS, LA was safe and led to better functional outcomes at 3 months compared to CS. Given its simplicity and potential benefits, LA warrants greater consideration in clinical practice and inclusion as a treatment arm in future randomized controlled trials studying the optimal anesthetic strategy for EVT.


  • Understanding what ‘what we do’ does

    by Jean Raymond, George Nilton Nunes Mendes, Tim E. Darsaut

  • Open Access

    Neurovascular complications of antiphospholipid syndrome: a narrative review

    by George Nilton Nunes Mendes, Alessandra Braga Cruz Guedes de Morais, Laura Catherine Gioia, Grégory Jacquin, Alexandre Y. Poppe, Felipe Hideki Soga, João Brainer Clares de Andrade

    Background Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by thrombosis, pregnancy complications, and other nonthrombotic manifestations in the presence of antiphospholipid antibodies. Neurovascular complications, including ischemic stroke, cerebral venous thrombosis and cognitive impairment, pose significant challenges in management. Objective To comprehensively review relevant and updated clinical aspects of neurovascular manifestations of APS. Methods We conducted a narrative review using the PubMed, EMBASE, and Cochrane Library databases with medical terms related to APS and its neurovascular manifestations. English-language studies, published between January 1, 2015, and March 2024, were included. Key publications outside this timeframe were also considered. Studies with higher levels of evidence, such as randomized controlled trials and meta-analyses, were prioritized for inclusion. Results Stroke is a prevalent complication in APS, with arterial thrombosis being a predominant mechanism. Despite recent trials, direct oral anticoagulants (DOACs) have not shown superiority over vitamin K antagonists (VKAs) for secondary prevention in this population. Cerebral venous thrombosis (CVT), although rare, can also occur in APS, and while DOACs have shown promise as a treatment in a general population, caution is warranted due to potential harm. Cognitive impairment affects a considerable proportion of APS patients, with thrombotic and nonthrombotic mechanisms contributing to its pathophysiology. Future research should focus on optimal management strategies for cognitive impairment and the efficacy of anticoagulation and immunosuppression. Conclusion Understanding the complex interplay of neurovascular manifestations in APS is essential for guiding clinical decisions and improving patient outcomes. Despite advancements, some challenges remain in establishing effective preventive and treatment measures, highlighting the need for further research in this field.


  • Development of a new scale for self-reported procedural patient comfort during endovascular therapy for acute stroke

    by George Mendes, Alexandre Y. Poppe, Olena Bereznyakova, Yan Deschaintre, Laura Gioia, Celine Odier, Christian Stapf, Gregory Jacquin

    Introduction: In stroke patients with acute large vessel occlusion, endovascular therapy (EVT) may be performed with or without sedation. Our aim is to describe self-reported intraprocedural comfort in patients undergoing EVT depending on sedation type. Methods: We performed a prospective observational single-center study of patients undergoing EVT. Patients were systematically interviewed on the day following intervention using a structured questionnaire addressing five domains (nausea/vomiting, pain of any kind, physical discomfort, emotional discomfort, and medical team interaction). Each domain scored 0 to 2 points for a maximum total of 10 points (a higher score indicating greater discomfort). In addition, satisfaction with procedural comfort was rated on a visual analog scale (VAS), and patients reported whether they would have preferred more, less, or the same amount of sedation. Patients who underwent EVT without sedation (local anesthesia, LA) were compared to those who received procedural sedation (conscious sedation, CS). Results: Seventy-seven questionnaires were completed: 37 (48%) patients underwent EVT with CS while 40 (52%) were treated under LA. Median scores on the self-reported discomfort scale (1[0–2] vs 1[0–2], p = 0.70) and mean scores on VAS (76 ± 25 vs 81 ± 24, p = 0.37) were similar between the CS and the LA group. The proportion of patients who were satisfied with the adopted sedation strategy was similar between groups. Conclusion: EVT without prior sedation seems to be well tolerated. Systematic self-evaluation of patient comfort appears feasible and may become integrated into routine clinical care. Patient-oriented outcomes should be included in future trials of sedation during thrombectomy.


  • Simultaneous multiple cervical vessel dissection manifested as pulsatile tinnitus

    by George Nilton Nunes Mendes, Laurent Letourneau-Guillon, Yan Deschaintre

    A previously healthy 43-year-old woman with Wallenberg syndrome, stemming from a left vertebral artery dissection and resulting in a left lateral medulla oblongata infarct, was later diagnosed with simultaneous bi-carotid and right V3 dissection. Seven days post-admission, she experienced sudden right-sided pulsatile tinnitus and exhibited a right-sided carotid murmur. High-resolution vessel wall MR imaging confirmed the new dissections. While spontaneous cervical vessel dissections involving more than two arteries are rare (less than 2% of cases), the prognosis is generally favorable. This case is noteworthy for presenting pulsatile tinnitus as a rare post-stroke dissection recurrence symptom, as documented in medical literature.


  • Alajouanine-Akerman's sign due to a thalamic infarct

    by G.N.N. Mendes, A. Braga Cruz Guedes de Morais, M.M. Santos Ramos, N.A. Ferreira Frota, F.M. Maia Carvalho, F. Oliveira Lima